451 related articles for article (PubMed ID: 31101085)
1. Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin.
Otabil KB; Gyasi SF; Awuah E; Obeng-Ofori D; Atta-Nyarko RJ; Andoh D; Conduah B; Agbenyikey L; Aseidu P; Ankrah CB; Nuhu AR; Schallig HDFH
BMC Infect Dis; 2019 May; 19(1):431. PubMed ID: 31101085
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin.
Otabil KB; Ankrah B; Bart-Plange EJ; Donkoh ES; Avarikame FA; Ofori-Appiah FO; Babae TN; Kudzordzi PC; Darko VA; Ameyaw J; Bamfo JG; Sakibu RA; Antwi-Berko D; Fodjo JNS; Basáñez MG; Schallig HDFH; Colebunders R
Infect Dis Poverty; 2023 Aug; 12(1):75. PubMed ID: 37587500
[TBL] [Abstract][Full Text] [Related]
3. Persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle belt of Ghana.
Otabil KB; Basáñez MG; Ankrah B; Opoku SA; Kyei DO; Hagan R; Ababio R; Bart-Plange EJ; Babae TN; Kudzordzi PC; Darko VA; Bamfo JG; Ameyaw J; Raji AS; Hadermann A; Schallig HDFH; Colebunders R
Trop Med Int Health; 2023 Nov; 28(11):844-854. PubMed ID: 37846505
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.
Osei-Atweneboana MY; Eng JK; Boakye DA; Gyapong JO; Prichard RK
Lancet; 2007 Jun; 369(9578):2021-2029. PubMed ID: 17574093
[TBL] [Abstract][Full Text] [Related]
5. Onchocerciasis situation in the Tukuyu focus of southwest Tanzania after ten years of ivermectin mass treatment.
Mweya CN; Kalinga AK; Kabula B; Malley KD; Ruhiso MH; Maegga BT
Tanzan Health Res Bull; 2007 Sep; 9(3):174-9. PubMed ID: 18087895
[TBL] [Abstract][Full Text] [Related]
6. Status of parasitological indicators and morbidity burden of onchocerciasis after years of successive implementation of mass distribution of ivermectin in selected communities of Yeki and Asosa districts, Ethiopia.
Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
BMC Public Health; 2020 Aug; 20(1):1233. PubMed ID: 32787813
[TBL] [Abstract][Full Text] [Related]
7. Does onchocerciasis transmission take place in hypoendemic areas? a study from the North Region of Cameroon.
Katabarwa MN; Eyamba A; Chouaibou M; Enyong P; Kuété T; Yaya S; Yougouda A; Baldiagaï J; Madi K; Andze GO; Richards F
Trop Med Int Health; 2010 May; 15(5):645-52. PubMed ID: 20345553
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of onchocerciasis, attitudes and practices and the treatment coverage after 15 years of mass drug administration with ivermectin in the Tombel Health District, Cameroon.
Nyagang SM; Cumber SN; Cho JF; Keka EI; Nkfusai CN; Wepngong E; Tsoka-Gwegweni JM; Fokam EB
Pan Afr Med J; 2020; 35():107. PubMed ID: 32637005
[TBL] [Abstract][Full Text] [Related]
9. Effects of the suspension of mass drug administration during the COVID-19 pandemic on onchocerciasis prevalence in the Bandjoun and Massangam health districts, West Region of Cameroon.
Shintouo CM; Shey RA; Yengo BN; Yaah NE; Teh RN; Ngwese RA; Ayong L; Vanhamme L; Souopgui J; Ghogomu SM; Njemini R
Acta Trop; 2023 Oct; 246():106999. PubMed ID: 37549841
[TBL] [Abstract][Full Text] [Related]
10. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
[TBL] [Abstract][Full Text] [Related]
11. Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection.
Vieira JC; Cooper PJ; Lovato R; Mancero T; Rivera J; Proaño R; López AA; Guderian RH; Guzmán JR
BMC Med; 2007 May; 5():9. PubMed ID: 17521449
[TBL] [Abstract][Full Text] [Related]
12. Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.
Tekle AH; Elhassan E; Isiyaku S; Amazigo UV; Bush S; Noma M; Cousens S; Abiose A; Remme JH
Parasit Vectors; 2012 Feb; 5():28. PubMed ID: 22313631
[TBL] [Abstract][Full Text] [Related]
13. Point prevalence mapping reveals hotspot for onchocerciasis transmission in the Ndikinimeki Health District, Centre Region, Cameroon.
Aza'ah RA; Sumo L; Ntonifor NH; Bopda J; Bamou RH; Nana-Djeunga HC
Parasit Vectors; 2020 Oct; 13(1):519. PubMed ID: 33066826
[TBL] [Abstract][Full Text] [Related]
14. Differential susceptibility of Onchocerca volvulus microfilaria to ivermectin in two areas of contrasting history of mass drug administration in Cameroon: relevance of microscopy and molecular techniques for the monitoring of skin microfilarial repopulation within six months of direct observed treatment.
Abong RA; Amambo GN; Chounna Ndongmo PW; Njouendou AJ; Ritter M; Beng AA; Esum ME; Deribe K; Fru-Cho J; Fombad FF; Nji TM; Enyong PI; Poole CB; Pfarr K; Hoerauf A; Carlow CKS; Wanji S
BMC Infect Dis; 2020 Oct; 20(1):726. PubMed ID: 33008333
[TBL] [Abstract][Full Text] [Related]
15. A Reevaluation of the Tolerability and Effects of Single-Dose Ivermectin Treatment on Onchocerca volvulus Microfilariae in the Skin and Eyes in Eastern Ghana.
Opoku NO; Gyasi ME; Doe F; Lew D; Hong AR; Chithenga S; Fischer PU; King CL; Weil GJ
Am J Trop Med Hyg; 2021 Nov; 106(2):740-745. PubMed ID: 34844204
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of onchocerciasis in the Fundong Health District, Cameroon after 6 years of continuous community-directed treatment with ivermectin.
Kamga HL; Shey DN; Assob JC; Njunda AL; Nde Fon P; Njem PK
Pan Afr Med J; 2011; 10():34. PubMed ID: 22187616
[TBL] [Abstract][Full Text] [Related]
17. Field-Based Evidence of Single and Few Doses of Annual Ivermectin Treatment Efficacy in Eliminating Skin Microfilaria Load after a Decade of Intervention.
Osue HO
Ethiop J Health Sci; 2017 Mar; 27(2):129-138. PubMed ID: 28579708
[TBL] [Abstract][Full Text] [Related]
18. Proteinuria and onchocerciasis in an endemic area in Cameroon under community-based treatment with ivermectin.
Ebong CE; Alemnji GA; ; Ashuntantang G; Asonganyi T
Trop Doct; 2007 Jul; 37(3):156-8. PubMed ID: 17716503
[TBL] [Abstract][Full Text] [Related]
19. Knowledge, attitude and practice of community drug distributors' about onchocerciasis and community directed treatment with ivermectin in Quara district, North Western Ethiopia.
Weldegebreal F; Medhin G; Weldegebriel Z; Legesse M
BMC Res Notes; 2016 Apr; 9():206. PubMed ID: 27053243
[TBL] [Abstract][Full Text] [Related]
20. Geographical distribution and species identification of human filariasis and onchocerciasis in Bioko Island, Equatorial Guinea.
Ta TH; Moya L; Nguema J; Aparicio P; Miguel-Oteo M; Cenzual G; Canorea I; Lanza M; Benito A; Crainey JL; Rubio JM
Acta Trop; 2018 Apr; 180():12-17. PubMed ID: 29289559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
